Bigul

Nureca Ltd - 543264 - Closure of Trading Window

Reference to our letter dated September 29, 2022, wherein we have informed that the trading window for dealing in equity shares of the Company will be closed from September 30, 2022 (Friday) till the completion of 48 hours after the declaration of unaudited financial results of the Company for the quarter and half year ending September 30,2022. It is hereby clarified that the trading window shall be closed after the business hours on September 30, 2022 (Friday).
30-09-2022
Bigul

Nureca Ltd - 543264 - Closure of Trading Window

Trading Window for dealing in the equity shares of the Company will remain closed from September 30, 2022 (Friday) till the completion of 48 hours after the declaration of unaudited financial results of the Company for the quarter and half year ending 30 September, 2022
29-09-2022
Bigul

Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Intimation under Securities and Exchange Board of India ('SEBI') (Prohibition of Insider Trading) Regulations, 2015
20-09-2022
Bigul

Nureca Ltd - 543264 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Nureca Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
10-09-2022
Bigul

Nureca Ltd - 543264 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Voting results of Annual General Meeting (AGM) and Consolidated scrutinizer''s Report
10-09-2022
Bigul

Nureca Ltd - 543264 - Shareholder Meeting / Postal Ballot-Outcome of AGM

PROCEEDINGS OF 6TH ANNUAL GENERAL MEETING OF THE COMPANY.
10-09-2022
Bigul

Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Notice of 06TH AGM through VC/OAVM, Remote E-Voting and Book Closure Information
17-08-2022
Bigul

Nureca Ltd - 543264 - Reg. 34 (1) Annual Report.

Notice of 6th Annual General Meeting and Annual Report 2022
16-08-2022
Bigul

Q1FY23 Quarterly Result Announced for Nureca Ltd.

Healthcare Supplies firm Nureca announced Q1FY23 Result : GMV of Q1’FY23 stood at Rs. 338 mn as compared to Rs. 1627 Mn in Q1’FY22, decrease of 79% Operating Revenue was Rs. 255 mn in Q1’FY23 as compared to Rs. 1,195 in Q1’FY22, decrease of 79% Overall, demand has seen a dip in Q1’FY23 as compared to the same quarter last year, which had seen a huge surge in demand due to Covid-19 Our Gross margins in Q1’FY23 were impacted due to lower demand, inflation in input cost, currency fluctuation as well as inflationary pressure in other non-core costs such as packaging, transport, etc. Our employee cost has increased as compared to the same quarter last year due to aggressive talent acquisition across the business functions and verticals majorly for app development and expansion of Offline distribution network. Other expenses are lower in Q1’FY23 by 52%, in line with the top line. Overall, EBITDA was Rs. (46) mn in Q1’FY23, lower by 109% and PAT stood at Rs. (41) mn, lower by 111% Result PDF
15-08-2022
Bigul

Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed copies of the newspaper publication of the Unaudited financial results for the first quarter ended June 30, 2022
14-08-2022
Next Page
Close

Let's Open Free Demat Account